Mitchell Kapoor
Analyst
H.C. Wainwright
Equibles does not estimate personal net worth.
About Mitchell Kapoor
Mitchell Kapoor is recorded as Analyst at H.C. Wainwright. Mitchell Kapoor has spoken on 5 earnings calls and 4 other investor events across 6 companies, most recently for Halozyme Therapeutics, Inc. on September 16, 2026. Those appearances were for Summit Therapeutics Inc. (SMMT), CytomX Therapeutics, Inc. (CTMX), Halozyme Therapeutics, Inc. (HALO), Kyverna Therapeutics, Inc. (KYTX), Palisade Bio, Inc. (PALI) and 1 other company. The companies whose calls Mitchell Kapoor spoke on are classified in the Healthcare sector.
Mitchell Kapoor on recent calls
“I'm a senior biotech analyst at H.C. Wainwright. Thank you for joining us for our third day of the H.C. Wainwright conference here in New York. Today, I have the pleasure of welcoming the Halozyme team, and I have the chief executive officer and president, Helen Torley, and chief financial officer, Darren Snellgrove.”
“I'm a senior biotech analyst at H.C. Wainwright. It's my pleasure today to welcome you all to the Fireside Chat with Kyberna. From the company, I have the CEO, Warner Biddle.”
“I'm a senior biotech analyst at H.C. Wainwright. Today, I have the pleasure of having Palisade Bio with us for a fireside chat. And from the company, I have J.D. Finley and Mitch Jones.”
“I'm a senior biotech analyst at H.C. Wainwright. It is my pleasure to welcome you all to the Cartesian Fireside Chat, and I have the great privilege of introducing Carson Bruin, the CEO of Cartesian.”
“With Harmony under consideration from the FDA, could you walk through your high-level thoughts on pricing strategy given the competitive landscape in EGFR, non-small cell lung cancer, but also the benefit of Ivanesimab, what it could provide in future expansion indications?”
Affiliation history
-
H.C. Wainwright
Analyst
Transcript header (unverified)
Current
Company network
Palisade Bio, Inc.
PALI
Biotechnology · Healthcare
1 appearance
Latest appearance 2026-09-14
View calls and events